Isolate Data
Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
JCS-C27 | C27W24 | Spain | 1996 | HIV1 | B | Plasma | None |
Treatment History
Order | Regimen | Weeks |
1 | AZT+DDC | 24 |
2 | 3TC+AZT+DDC | 24 |
RT Sequence
NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
D67N, K70R, M184V | T215S, K219Q | K64H, T69N, K122P, D177E, Q207E, L228H | L210G, P217Q |
>C27W24| codons 1-259 PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPV FAIHKKNSNRWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPL DPDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPEIVI YQYVDDLYVGSDLEIGQHRTKIEELREHLGRWGFSTQDQKHQKEPPFHWMGYELHPDKWT VQPIVLPEKDSWTVNDIQK |
References
Author | Title | Citation |
Ruiz, L | Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC. | AIDS, 1996 |
Gonzales, MJ | Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors. | AIDS, 2003 |
Rhee, SY | HIV-1 protease and reverse transcriptase mutations: Correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance. | J Infect Dis, 2005 |